Fact CheckerSign in

NCT04022499Completed

Presessions for the National Diabetes Prevention Program

Enhanced Enrollment in the National Diabetes Prevention Program for the Underserved: a Randomized Control Trial

Source: ClinicalTrials.gov · Last updated 9 Sept 2026

Brief summary (registry, in English)

The National Diabetes Prevention Program (NDPP) is a widely available, evidence-based intervention that promotes weight loss to prevent type 2 diabetes; however, participant attendance is problematic and leads to suboptimal weight loss, especially among Hispanic, non-Hispanic black, and low-income non-Hispanic white participants. An innovative pre-session enhancement to the NDPP (Pre-NDPP) showed successful results upon initial application in a diverse and predominately low-income population, with doubled attendance and weight loss outcomes as compared to previous NDPP participants who did not receive a pre-session. If Pre-NDPP is shown to be successful upon more rigorous study, it can be widely adopted by NDPP providers across the country to help reduce diabetes prevalence and related health disparities.

Status (registry)
Completed
Study type
Interventional
Enrollment
483 (actual)
First submitted
15 Jul 2019
Start date
6 Aug 2019
Primary completion date
29 Apr 2024
Lead sponsor
Denver Health and Hospital Authority
Diseases
Obesity
NCT number
NCT04022499

What you commit to

  • Study type: Interventional
  • Participants enrolled: 483
  • From 6 Aug 2019 to the primary completion date, 29 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Known to have diabetes

Other

  • Pregnant at enrollment
  • Non-English or non-Spanish-speaking.

Who the study is looking for

  • Denver Health patients
  • BMI≥25 (≥23 if Asian)
  • History of recent prediabetes or former gestational diabetes (GDM) diagnosis (patients without known prediabetes or past GDM may also be eligible based on a risk screening tool)

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Denver Health
Coordinator of this site? Confirm its status
DenverUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.